Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-24-027797

Chief Executive Officer disposed of 53,118 shares (other)

  • Chief Executive Officer acquired 53,118 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Backer Marianne Chief Executive Officer 2024-06-12 Other disposition −53,118 625,339 D
De Backer Marianne Chief Executive Officer 2024-06-12 Other acquisition +53,118 53,118 I
Loading xslF345X05/wk-form4_1718222423.xml…